Global Growth/Differentiation Factor 8 Market Survey and Trend Research 2018

June 2018 | 84 pages | ID: G8572A13644EN
99Strategy

Abstracts

SUMMARY

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Acceleron Pharma, Inc., Atara Biotherapeutics, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Pfizer Inc., Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sarepta Therapeutics, Inc., Scholar Rock, Inc. etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Growth/Differentiation Factor 8 Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 GROWTH/DIFFERENTIATION FACTOR 8 MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 Key Companies List
4.1 Acceleron Pharma, Inc. (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Atara Biotherapeutics, Inc. (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Bristol-Myers Squibb Company (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Eli Lilly and Company (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Pfizer Inc. (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Pfizer Inc. (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Regeneron Pharmaceuticals, Inc. (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Sarepta Therapeutics, Inc. (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Scholar Rock, Inc. (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Growth/Differentiation Factor 8 Market 2012-2017, by Type, in USD Million
Table Global Growth/Differentiation Factor 8 Market 2012-2017, by Type, in Volume
Table Global Growth/Differentiation Factor 8 Market Forecast 2018-2023, by Type, in USD Million
Table Global Growth/Differentiation Factor 8 Market Forecast 2018-2023, by Type, in Volume
Table Acceleron Pharma, Inc. Overview List
Table Growth/Differentiation Factor 8 Business Operation of Acceleron Pharma, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Atara Biotherapeutics, Inc. Overview List
Table Growth/Differentiation Factor 8 Business Operation of Atara Biotherapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Overview List
Table Growth/Differentiation Factor 8 Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly and Company Overview List
Table Growth/Differentiation Factor 8 Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Inc. Overview List
Table Growth/Differentiation Factor 8 Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Inc. Overview List
Table Growth/Differentiation Factor 8 Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Regeneron Pharmaceuticals, Inc. Overview List
Table Growth/Differentiation Factor 8 Business Operation of Regeneron Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sarepta Therapeutics, Inc. Overview List
Table Growth/Differentiation Factor 8 Business Operation of Sarepta Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Scholar Rock, Inc. Overview List
Table Growth/Differentiation Factor 8 Business Operation of Scholar Rock, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Growth/Differentiation Factor 8 Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Growth/Differentiation Factor 8 Sales Revenue Share, by Companies, in USD Million
Table Global Growth/Differentiation Factor 8 Sales Volume 2012-2017, by Companies, in Volume
Table Global Growth/Differentiation Factor 8 Sales Revenue Share, by Companies in 2017, in Volume
Table Growth/Differentiation Factor 8 Demand 2012-2017, by Application, in USD Million
Table Growth/Differentiation Factor 8 Demand 2012-2017, by Application, in Volume
Table Growth/Differentiation Factor 8 Demand Forecast 2018-2023, by Application, in USD Million
Table Growth/Differentiation Factor 8 Demand Forecast 2018-2023, by Application, in Volume
Table Global Growth/Differentiation Factor 8 Market 2012-2017, by Region, in USD Million
Table Global Growth/Differentiation Factor 8 Market 2012-2017, by Region, in Volume
Table Growth/Differentiation Factor 8 Market Forecast 2018-2023, by Region, in USD Million
Table Growth/Differentiation Factor 8 Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Growth/Differentiation Factor 8 Industry Chain Structure
Figure Global Growth/Differentiation Factor 8 Market Growth 2012-2017, by Type, in USD Million
Figure Global Growth/Differentiation Factor 8 Market Growth 2012-2017, by Type, in Volume
Figure Global Growth/Differentiation Factor 8 Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Growth/Differentiation Factor 8 Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region